Best QMS Software for Medical Devices: An Honest Evaluation Guide for Regulated Manufacturers

Medical device quality professionals are experienced evaluators. They have seen vendor comparison pages where every criterion is chosen to make the vendor win, and they leave within seconds. This guide is written differently: it starts with the evaluation criteria that actually matter to a regulated medical device manufacturer, applies those criteria honestly to the leading platforms, identifies the genuine strengths and genuine limitations of each, and explains where eLeaP fits in that landscape. If eLeaP is not the right fit for your organisation’s specific situation, this guide will tell you that too.

The medical device QMS software market is not homogeneous. Greenlight Guru, MasterControl, Qualio, ETQ, and eLeaP each have real strengths and real limitations. The right platform depends on where your organisation sits in the device lifecycle, how large and complex your quality system is, what your regulatory market requirements are, and whether you need design controls, production quality management, or both. This guide maps those dimensions to the platforms that address them.

The Evaluation Framework: Eight Criteria That Regulated Medical Device Manufacturers Actually Need

The following eight criteria are drawn from the regulatory obligations of medical device manufacturers under 21 CFR Part 820 (QMSR), ISO 13485:2016, and ICH Q10. They are not invented to favor any particular platform. They are the requirements that an FDA investigator or a Notified Body auditor will examine during an inspection of a medical device quality system.

Criterion 1: ISO 13485 Certification Support and QMSR Alignment

The platform must support the quality system requirements of ISO 13485:2016 across all functional modules: document control, CAPA, supplier management, production controls, training, complaint handling, and audit management. Since the QMSR became effective in February 2026, US manufacturers need a system that satisfies both ISO 13485 and the QMSR simultaneously. A platform aligned to ISO 13485 satisfies the QMSR’s foundational requirements, with FDA’s supplemental QMSR requirements addressed through specific module configuration.

Criterion 2: Design Controls Coverage Under 820.30 and ISO 13485 Section 7.3

The platform must manage all nine design control elements of 820.30: planning, inputs, outputs, review, verification, validation, transfer, changes, and the Design History File. The DHF must be maintained as a connected record set with traceable relationships between inputs, outputs, and V&V activities — not as a document folder that contains the required records without demonstrating their relationships.

Criterion 3: Post-Market Production Quality Management

For manufacturers with cleared or approved devices, the platform must manage Device History Records that link production steps to the Device Master Record version in effect at the time of production, incoming inspection and supplier quality records, in-process and final acceptance testing records, and production nonconformance management with MRB disposition. This is the quality management of a manufacturing operation, not a development organisation.

Criterion 4: CAPA with Structured Root Cause and Verified Effectiveness

The CAPA workflow must support structured root cause analysis documentation, enforce effectiveness verification criteria defined before corrective action implementation, and prevent CAPA closure without a completed effectiveness verification sign-off. CAPA observations are among the most frequent FDA warning letter citations for medical device manufacturers. A CAPA system that allows closure without verified effectiveness is a documented compliance liability.

Criterion 5: Training Record Management Linked to Document Versions

ISO 13485 Section 6.2 requires competency records demonstrating that personnel performing work affecting product quality are trained on current procedures. The platform must connect training completion records to the specific document versions on which employees were trained, and must automatically generate retraining assignments when a controlled document is revised. Training records that reference superseded procedure versions generate inspection observations.

Criterion 6: Complaint Handling with MDR Evaluation Workflow

The complaint management module must support the intake fields required by 21 CFR Part 820.198, include a structured MDR evaluation workflow that walks through the Part 803 reportability criteria with documented rationale, and track MDR submission dates against the applicable 30-day or 5-day reporting windows. Complaint trending must surface patterns that trigger proactive quality management review.

Criterion 7: Audit Management and Inspection Readiness Reporting

The audit management module must support internal quality system audits, supplier audits, and mock inspection programs with configurable checklists, finding classification, and CAPA linkage. Inspection readiness reporting must generate a complete audit history with finding closure status and linked CAPA status on demand, without requiring data assembly from multiple systems.

Criterion 8: Computerized System Validation Support

The vendor must provide a validation support package that includes an executed Installation Qualification report, an Operational Qualification test library with executed results covering all 21 CFR Part 11-relevant functions, a Part 11 compliance traceability matrix, and Performance Qualification protocol templates. The vendor must provide advance notification of system changes with change assessment documentation supporting the customer’s change control evaluation.

Competitor Analysis: Greenlight Guru, MasterControl, Qualio, ETQ, and eLeaP

The following assessments are factual characterisations of each platform based on its public positioning, documented product capabilities, and competitive position in the medical device QMS market. This is not a feature-count comparison. It is an assessment of fit for the evaluation criteria above.

Greenlight Guru

Greenlight Guru’s brand is built on FDA design controls for medical device startups. Their product is purpose-built for the pre-market development phase, with strong DHF management, design input-to-output traceability, and content resources that are genuinely useful for teams navigating their first 510(k). Their market positioning is explicit: they target early-stage companies and the regulatory consultants who serve them.

The limitation is the lifecycle scope. Greenlight Guru is optimised for Criteria 2 (design controls) and partially addresses Criteria 1 (ISO 13485 documentation). It does not address Criterion 3 (post-market production quality) with the DHR-to-DMR traceability and production nonconformance management that a manufacturer with cleared products needs. It does not address Criterion 5 (training records) through an integrated LMS — training management is outside their product scope. The platform is the right fit for a pre-revenue startup or a company actively working through 510(k) preparation. It is not the right fit for a mid-market manufacturer with cleared products, a production floor, and ongoing production quality management obligations.

Validation posture: Greenlight Guru provides a validation support package. The depth of IQ/OQ/PQ documentation and Part 11 traceability matrix coverage should be assessed against the customer’s specific validation requirements.

MasterControl

MasterControl is an enterprise-grade quality and compliance platform with strong brand recognition and a long track record in regulated industries. Their product addresses a broad functional scope across document control, CAPA, training, audit management, and supplier quality. Enterprise pharmaceutical and medical device manufacturers with large quality teams and dedicated IT resources to manage the implementation are the buyers MasterControl serves well.

The limitation is complexity and cost relative to the mid-market buyer. MasterControl’s implementation timeline, configuration complexity, and total cost of ownership position it for enterprise organisations with the resources to manage a complex implementation and the ongoing administrative burden of maintaining a heavily configured system. Mid-market medical device manufacturers with quality teams of 5 to 20 people consistently report that MasterControl’s complexity exceeds their operational needs. The platform is the right fit for large, complex regulatory environments. It is not cost-justified for a 100-person medical device manufacturer with one cleared product and a straightforward quality system.

Validation posture: MasterControl provides comprehensive validation documentation. This is one of their genuine strengths.

Qualio

Qualio is a cloud-based quality management platform that markets primarily to pharmaceutical and biotech companies. Their product is clean and modern, with document control, CAPA, and training functionality that serves small-to-mid-size pharma and biotech organisations well. Their content positioning is pharma-first, and their product design reflects that: batch record management and pharmaceutical-specific deviation workflows are stronger than medical device-specific capabilities.

The limitation for medical device buyers is regulatory depth. Qualio’s design controls coverage under Criterion 2 is limited relative to a platform built specifically for medical device manufacturers. Their complaint handling under Criterion 6 does not include a structured MDR evaluation workflow with Part 803 reportability criteria. The platform is a reasonable fit for a pharma-first organisation that also has some medical device products. It is not the right fit for a dedicated medical device manufacturer where ISO 13485 compliance, DHF management, and MDR evaluation are primary quality system requirements.

Validation posture: Qualio provides validation documentation. The Part 11 traceability coverage and IQ/OQ protocol depth should be assessed during vendor evaluation.

ETQ (Hexagon)

ETQ is a broad quality management platform owned by Hexagon, addressing quality, compliance, health and safety, and environmental management across regulated and general manufacturing industries. Their product addresses the full QMS function scope, and Hexagon’s enterprise resources provide stability and investment in the platform. Their organic search presence in the medical device QMS space is limited relative to their product capability, which creates a positioning gap that does not reflect the platform’s actual breadth.

The limitation for mid-market medical device buyers is scope mismatch in the opposite direction from Greenlight Guru. ETQ’s breadth across quality, compliance, EHS, and environmental management creates an implementation scope that exceeds what a mid-market medical device manufacturer typically needs. The platform is better suited to multi-industry enterprise organisations that need a single platform across quality and EHS functions. A dedicated medical device quality team evaluating ETQ against a narrower platform will find that the configuration required to implement the medical-device-specific workflows adds implementation time and cost relative to a purpose-built medical device QMS.

Validation posture: ETQ provides validation documentation consistent with enterprise quality platform expectations.

eLeaP

eLeaP targets the segment that the other platforms do not serve optimally: the mid-market medical device manufacturer that has cleared products in production, needs full quality system coverage from design controls through production quality management, and requires an integrated training management capability without maintaining a separately validated LMS. The platform’s strongest differentiation against each competitor is specific.

Against Greenlight Guru: eLeaP covers the post-market production quality management scope (Criterion 3) that GG does not, including DHR-to-DMR traceability, production nonconformance management, and the MDR evaluation workflow. The native LMS satisfies Criterion 5 (training records linked to document versions) without a separate system.

Against MasterControl: eLeaP delivers equivalent functional coverage at mid-market scale and pricing, with a shorter implementation timeline and lower ongoing administrative burden. The platform is not enterprise-grade in the complexity sense that MasterControl is — it is deliberately configured for organisations that need a robust QMS without an IT team to manage it.

Against Qualio: eLeaP’s medical device regulatory depth on design controls, DHF management, MDR evaluation, and ISO 13485 Section 7.3 is greater. Buyers who are primarily pharmaceutical with some device products will find Qualio adequate. Buyers who are primarily medical device buyers will find eLeaP’s device-specific depth more appropriate.

Against ETQ: eLeaP is narrower by design — QMS and LMS for regulated industries, without the EHS and environmental management scope that ETQ carries. A dedicated medical device quality team will find eLeaP’s implementation scope and configuration requirements proportionate to their needs.

Where eLeaP is not the right fit: a pre-revenue startup focused exclusively on design controls and 510(k) submission preparation may find Greenlight Guru’s development-phase depth more directly relevant. A large enterprise manufacturer with a dedicated IT quality team and multi-geography, multi-product quality system complexity may find MasterControl’s enterprise capabilities justified.

Validation posture: eLeaP provides a full validation support package, including an executed IQ report, OQ test library with executed results, 21 CFR Part 11 traceability matrix, CSA risk classification documentation, PQ protocol templates, and advanced change notification with change assessment documentation. The package is available for review during the procurement evaluation phase.

Criteria Scorecard: Eight Requirements Across Five Platforms

The following table summarises the assessment of each platform against the eight evaluation criteria. Ratings reflect the platform’s fit for a mid-market medical device manufacturer in active production under ISO 13485 and QMSR.

Key: ✓ = Addresses the criterion with appropriate depth | △ = Partially addresses | ✗ = Does not address or addresses inadequately for the target buyer

ISO 13485 / QMSR Alignment

GG: △ (design phase only)   MasterControl: ✓   Qualio: △ (pharma-first)   ETQ: ✓   eLeaP: ✓

Design Controls (820.30 / 7.3)

GG: ✓ (pre-market depth)   MasterControl: ✓   Qualio: △   ETQ: ✓   eLeaP: ✓

Post-Market Production Quality

GG: ✗   MasterControl: ✓   Qualio: △   ETQ: ✓   eLeaP: ✓

CAPA with Verified Effectiveness

GG: △   MasterControl: ✓   Qualio: △   ETQ: ✓   eLeaP: ✓

Training Linked to Doc Versions

GG: ✗ (no native LMS)   MasterControl: ✓   Qualio: ✓   ETQ: ✓   eLeaP: ✓

Complaint Handling + MDR Eval

GG: △   MasterControl: ✓   Qualio: △   ETQ: ✓   eLeaP: ✓

Audit Management + Inspection Readiness

GG: △   MasterControl: ✓   Qualio: ✓   ETQ: ✓   eLeaP: ✓

CSV / Validation Support Package

GG: ✓   MasterControl: ✓   Qualio: △   ETQ: ✓   eLeaP: ✓

How to Use This Guide in Your Procurement Process

The eight criteria above should form the basis of your demo script for each platform under evaluation. Request that each vendor demonstrate their platform against each criterion in their actual software, not in slides or documentation. For complex criteria like CAPA effectiveness verification and training-to-document-version linkage, ask for a live workflow demonstration rather than a feature description.

The questions most commonly missed in medical device QMS evaluations are: how does the platform handle post-market design changes that link to CAPAs, what happens to the training matrix when an employee changes roles, what does the MDR evaluation workflow look like for a device malfunction complaint with a potential serious injury outcome, and what is the process for evaluating the impact of a platform update on the validated state. Ask all four in every demo.

For validation assessment, request the vendor’s validation support package before shortlisting. The presence or absence of an executed IQ report, an OQ test library with 21 CFR Part 11 traceability, and PQ protocol templates tells you immediately whether the vendor treats computerized system validation as a customer-owned obligation or as a shared responsibility. Any vendor who cannot produce these documents before the contract should not be on your shortlist for a GxP system.

eLeaP’s demo for medical device manufacturers covers the DHF record network and traceability matrix, the post-market design change workflow with CAPA linkage, the MDR evaluation workflow for a device complaint, and the training completion gate on document revision against a configuration reflecting the buyer’s device type and regulatory market. The validation support package is available for review before the demo if needed. Request a scoped evaluation at eleapsoftware.com.

Related resources:

• Medical Device QMS Software
• ISO 13485 Software 
• Medical Device Quality Management Software
• FDA Design Controls Software